How long does it take for resistance to Sotorasib to develop? This article gives you the answer

About Sotorasib (Sotorasib)Resistance is a common and complex problem in anti-cancer treatment. The development of drug resistance involves multiple factors, some of which may be related to the characteristics of the drug, individual patient differences, tumor characteristics, and treatment strategies.

First, understanding the mechanism of action of a drug is critical to understanding the development of drug resistance. As a drug that targets KRAS gene mutations, the mechanism involves inhibiting the abnormally active KRAS protein, thereby inhibiting the growth of cancer cells. However, tumor cells may develop resistance to drugs through a variety of pathways.

A common resistance mechanism is pre-existing resistance mutations that are present early in treatment. The presence of these mutations in tumor cells makes them less responsive to drugs, making them less effective. In addition, some repair mechanisms within cells may also play a role in drug resistance.

Another aspect is subsequent variation during treatment. Cancer cells can develop mutations during treatment, causing cells that were originally sensitive to a drug to become resistant to the drug, which is called acquired drug resistance.

With these concepts in mind, we can discuss the specifics of Soto Rasib. Sotoraxib is a relatively new drug, and clinical studies have focused primarily on its preliminary efficacy and safety. More time of observation and research may be needed to gain an in-depth understanding of its resistance mechanism and how patients respond to long-term medication.

Clinical trials and observational studies are often used in medical research to monitor patient responses to drugs and detect any potential resistance as early as possible. In practical applications, doctors usually regularly evaluate the effectiveness of treatment plans based on the patient's specific conditions and may make adjustments as needed.

Ultimately, understanding the long-term use and resistance of sotoraxib requires attention to the latest clinical studies, published literature, and pharmaceutical company reports. As the medical field continues to evolve, it is recommended to consult a professional doctor or a professional organization engaged in relevant research to obtain the latest and most accurate information.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The original version of sotorasibu in Hong Kong, China, has the specifications of 120mg*240 tablets and the price is 8The price of the European version of the original drug of the same specifications is around 40,000, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.